Healthcare at Home claims damages from Genzyme

Notice (2 pages, PDF) of a claim for compensatory damages, exemplary damages, account of profits and costs by Healthcare at Home against Genzyme. This follows from the OFT and CAT findings that Genzyme had abused a dominant position in its handling of arrangements for the provision of homecare for Gaucher disease patients using its drug Cerezyme. See Genzyme for background.

For further information or advice please contact Franck Latrémolière.

Filed under Article 82, CAT, Healthcare, Pharmaceuticals.

Reckon LLP is an economics consultancy with expertise in data analysis, economic regulation and competition law.

About Reckon